Blood rheology in children with the S/β+-thalassemia syndrome

Céline Renoux1,2,3, Philippe Joly1,2,3, Alexandra Gauthier1,2,4

  • 1Univ Lyon, Université Claude Bernard Lyon 1, Laboratoire Interuniversitaire de Biologie de la Motricité (LIBM) EA7424, Team « Vascular Biology and Red Blood Cell », Villeurbanne, France.

Insights

Sickle cell disease (SS) and related conditions impact blood flow and red blood cell (RBC) function. Severe S/β+-thalassemia patients show impaired vascular function, indicated by altered nitric oxide and nitrotyrosine levels.

Area of Science:

  • Hematology
  • Vascular Biology
  • Pediatric Disease

Background:

  • Sickle cell disease (SS) and related hemoglobinopathies (SC, S/β+-thalassemia) are characterized by abnormal red blood cells (RBCs).
  • Blood rheology, including viscosity, RBC deformability, and aggregation, plays a crucial role in disease pathophysiology.
  • Understanding rheological differences and their clinical correlations is vital for managing these conditions in children.

Purpose of the Study:

  • To compare blood rheological parameters in children with SS, SC, S/β+-thalassemia, and healthy controls (AA).
  • To investigate the association between blood rheology and clinical severity, specifically vaso-occlusive crises (VOC), in S/β+-thalassemia patients.

Main Methods:

  • Blood viscosity, RBC deformability (ektacytometry), and RBC aggregation (syllectometry) were measured.
  • Nitric oxide (NOx) and nitrotyrosine levels were quantified.
  • Comparison between patient groups (SS, SC, S/β+-thalassemia) and healthy controls (AA).

Main Results:

  • SC patients exhibited lower RBC deformability and aggregation compared to S/β+-thalassemia patients.
  • Nitrotyrosine levels, a marker of oxidative stress, were lower in healthy and S/β+ individuals than in SS patients.
  • S/β+-thalassemia children with a history of VOC had lower NOx and higher nitrotyrosine levels than those without VOC.

Conclusions:

  • Blood rheology differs among sickle cell disease variants, with SC showing reduced RBC function compared to S/β+-thalassemia.
  • Oxidative stress markers are elevated in SS disease and correlate with clinical severity in S/β+-thalassemia.
  • Impaired vascular function may contribute to the severity of S/β+-thalassemia in children experiencing vaso-occlusive events.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
324
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
689
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.1K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.6K
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.1K
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
3.9K